Of the 69 deleterious mutations, 29 (29/69, 42%) were in BRCA1 and 40 (40/69, 58%) in BRCA2. There was no significant difference in the age of breast cancer diagnosis between BRCA carriers and non-BRCA carriers (p = 0.325, Wilcoxon test). The gene discussed is BRCA2; the disease is breast cancer.